Search Orphan Drug Designations and Approvals
-
| Generic Name: | dual vector gene therapy product containing recombinant adeno-associated viral vector serotype expressing full human OTOF protein |
|---|---|
| Date Designated: | 08/06/2024 |
| Orphan Designation: | treatment of otoferlin-mediated hearing Loss |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Suzhou Otovia Therapeutics Co., Ltd. 4F, Building 2, 367 Shengrong Road Pudong New Area Shanghai China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







